The bill H. 3092 aims to amend the South Carolina Code of Laws by adding Section 44-41-95, which mandates the disclosure of specific medical information to women receiving a chemically induced abortion, particularly when mifepristone is administered. The bill outlines that healthcare providers must provide a disclosure statement to the pregnant woman, which includes information about the effectiveness of mifepristone and options available if she regrets her decision after taking the first pill. The disclosure can be provided in various ways, such as stapling it to the medication package or attaching it to a prescription.

Additionally, the bill clarifies that it does not create or recognize a right to abortion, nor does it require the disclosure statement to be given to women experiencing a spontaneous miscarriage. It also specifies that the responsibility for providing the disclosure lies with the facility administering the abortion, not pharmacies or other entities. The bill includes definitions for terms such as "abortion pill," "mifepristone," "misoprostol," and "spontaneous miscarriage." If any part of the act is deemed unconstitutional, the remaining sections will still remain valid. The act will take effect upon the Governor's approval.

Statutes affected:
12/05/2024: 44-41-95
Latest Version: 44-41-95
12/06/2024: 44-41-95